Contact Us
Chengguan District, Lanzhou, Gansu, China
© 2025 Jeifer Pharmaceutical, All Right
Reserved.
Sodium Carboxymethyl Cellulose (CMC) with low substitution, referenced under the British Pharmacopoeia (BP), European Pharmacopoeia (EP), and United States Pharmacopeia (USP) pharma grades, stands as a critical material in modern pharmaceutical formulation. Developed through the chemical reaction of natural cellulose with monochloroacetic acid in the presence of an alkali like sodium hydroxide, CMC transforms the traditional plant fiber into a highly functional, water-soluble, anionic polymer. It plays a significant role as a binder, thickener, suspending agent, and stabilizer in various drug products, allowing for controlled release and desirable textural properties. The lower degree of substitution typically ranges from 0.4 to 0.7 carboxymethyl groups per glucose unit, which directly impacts its solubility, viscosity, and compatibility with sensitive active pharmaceutical ingredients. The pharma grade character comes from stringent purification procedures, eliminating impurities like sodium glycolate, microbial contaminants, and heavy metals, satisfying requirements for safety, purity, and performance set by regulatory authorities across the globe.
CMC forms a linear, high-molecular-weight chain based on a cellulose backbone, with certain hydrogen atoms replaced by carboxymethyl groups. The typical molecular formula reads as C8H15NaO8. Its molecular weight varies widely, but for pharmaceutical grade CMC, it often falls between 90,000 and 700,000 Daltons, allowing manufacturers to tune the viscosity and gel-forming abilities. Crystal-clear solutions rarely appear with CMC; instead, it yields colloidal, translucent liquids in water and hydrogels on account of the hydrogen bonding among its chains. Solid forms arrive at manufacturing facilities as white to off-white flakes, powders, small pearls, and even granular or fibrous material, each offering distinct solubility rates and handling characteristics. In liquid form, sodium carboxymethyl cellulose maintains full dispersibility even at relatively low concentrations, reflecting high surface activity and a strong ability to hold water.
Industrial shipments specify CMC at varying levels of purity and functional group substitution. BP, EP, and USP standards strictly regulate the sodium percentage (typically between 6.5-9.5%), pH of a 1% solution (generally around 6.0-8.5), and the degree of polymerization. Densities fall between 0.7 and 1.2 grams per cubic centimeter in solid form, though hydration radically increases apparent volume in application. Solutions of CMC remain stable over a wide pH range, key for oral, topical, and injectable pharmaceutical products. Viscosity, defined by the concentration and molecular weight, might range from thin syrups to thick pastes; for example, a 1% solution usually presents a dynamic viscosity from about 25 to over 1,000 mPa·s at 25°C. The HS Code for sodium carboxymethyl cellulose in its pharma grade largely follows 391231, which international customs officers deal with in the context of modified cellulose polymers.
Handling sodium carboxymethyl cellulose in the pharmaceutical space means addressing toxicology, purity, and eco-impact concerns directly. In routine application, CMC is recognized as a non-toxic, non-irritant material by the U.S. FDA and the EMA, provided it remains below prescribed impurity thresholds. The chemical is not classed as hazardous for transport under standard GHS rules, and pharmaceutical operators benefit from its low dusting grades, so workplace inhalation risk stays minimal. Sodium carboxymethyl cellulose does not bioaccumulate, does not trigger sensitization in skin contact, and breaks down under common wastewater conditions. Its water solubility—in flakes, powders, pearls, or liquids—simplifies cleaning in manufacturing, though strict batch control is required to keep residual processing aids or biological agents at near-undetectable levels. The product is generally free from heavy metals, residual organic solvents, and pesticide residues, screened regularly to exceed international standards for raw pharmaceutical ingredients.
Manufacturers and formulation chemists rely heavily on CMC with low substitution for creating stable suspensions, controlled viscosity, and reliable drug release in oral liquid preparations such as syrups, gels, and topical creams. Its unique molecular structure interacts easily with water, resulting in a rapid swelling action, thixotropic gel formation, and a smooth mouthfeel that improves patient acceptability. Blending CMC into tablet matrices increases friability resistance and ensures that compressed tablets hold together through packaging, shipment, and handling. Low substitution yields more pronounced gelling abilities, making it the backbone for thick emulsions and microencapsulated products designed for slow dissolution. Specialists in wound healing leverage CMC for moisture-retentive dressings and wound gels, while its inertness keeps it from reacting with antibiotics, analgesics, antihistamines, or flavoring agents. In regulated markets, validated analytical procedures confirm each batch’s purity, chain length, and degree of substitution, eliminating lot-to-lot variation that could otherwise threaten drug safety or performance.
Sourcing reliable, pharma-grade sodium carboxymethyl cellulose means vetting for quality, strength, and consistent functional outcomes. By balancing substitution level, physical form, and molecular characteristics, formulation teams push product boundaries, economize on excipient use, and drive global access to affordable medicines across a spectrum of disease states. Updates to BP, EP, and USP guidelines continue to elevate safety benchmarks, spurring new advances in cellulose chemistry, greener production pathways, and digital batch monitoring for full traceability—providing users and regulators with unmatched confidence in material safety and therapeutic reliability.
Chengguan District, Lanzhou, Gansu, China
